Research Article
Translation of a Diabetes Remission Service into Australian Primary Care: Findings from the Evaluation of DiRECT-Australia
Table 3
Changes in anthropometric, clinical, and biochemical measures at 12 and 52 weeks’ follow-up ().
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abbreviations: ALP: alkaline phosphatase; ALT: alanine transaminase; APRI: AST to platelet ratio index; AST: aspartate aminotransferase; BMI: body mass index; CI: confidence interval; DBP: diastolic blood pressure; eGFR: estimated glomerular filtration rate; FIB-4: fibrosis-4 index for liver fibrosis; GGT: gamma-glutamyl transferase; HbA1c: glycated haemoglobin; HDL: high-density lipoprotein; LDL: low-density lipoprotein; NAFLD: nonalcoholic fatty liver disease; SBP: systolic blood pressure; urine ACR: urine albumin-to-creatinine ratio. #Mean difference = follow-up value-baseline value. Note: values presented are unadjusted for multiple testing; values marked with an “” retained significance after Benjamini-Hochberg correction for multiple testing. eGFR was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. |